Freedom Meditech roped in $7 million in a Series B financing round in support of 2 diagnostic products for diabetes management, 1 already on the shelves and 1 still on the bench.
Freedom Meditech
A bold new vision for Meditech
I have no financial relationships with any EHR vendor, but feel a great affinity for the vendors in Massachusetts – eClinicalWorks, AthenaHealth and Meditech.
For the past few years, I’ve suggested to Meditech that cloud hosted, standards-based, web-centric and mobile enabled hospital information systems would be very welcome by the marketplace.
Diabetes: Glooko links up with Wal-Mart | Wall Street Beat
Breast Cancer: GE Healthcare lands FDA clearance for SenoBright system | Regulatory Roundup
GE Healthcare, a unit of General Electric Company (NYSE: GE) landed FDA 510(k) clearance for its SenoBright contrast enhanced spectral mammography for breast cancer diagnosis.
Launched in 2010, the SenoBright system is already used in France, Spain, Italy, Belgium, Germany, Austria and Japan.